Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma
Rebecca Rogers, Alan G. Mackay, Yura Grabovska, Diana Carvalho, Claire Dobinson, Anna Burford, Valeria Molinari, Rita Pereira, Laura Bevington, Ruth Ruddle, Josephine Nkrumah, Haider Tari, Jiin Song, Drenusha Sejdiu, Nicole Chew, , Chris Jones
This study identifies a combinatorial strategy using ALK2 inhibitors and statins to target metabolic dependencies in diffuse midline glioma.
bioRxiv · Sep 23, 2026 · PreprintCancer Biology